- Report
- April 2025
- 246 Pages
Global
From €5317EUR$5,850USD£4,553GBP
- Report
- April 2025
- 173 Pages
Global
From €5317EUR$5,850USD£4,553GBP
- Report
- April 2025
- 259 Pages
Global
From €5317EUR$5,850USD£4,553GBP
- Report
- April 2025
- 233 Pages
Global
From €5317EUR$5,850USD£4,553GBP
- Report
- April 2025
- 181 Pages
Global
From €5317EUR$5,850USD£4,553GBP
- Report
- April 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,495GBP
- Report
- March 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,495GBP
- Report
- March 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,495GBP
- Report
- March 2025
- 250 Pages
Global
From €4081EUR$4,490USD£3,495GBP
- Report
- March 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,495GBP
- Report
- March 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,495GBP
- Report
- January 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,495GBP
- Report
- August 2024
- 177 Pages
Global
From €2272EUR$2,500USD£1,946GBP
- Report
- May 2024
- 178 Pages
Global
From €2272EUR$2,500USD£1,946GBP
- Report
- January 2025
- 183 Pages
Global
From €4090EUR$4,500USD£3,502GBP
- Report
- July 2024
- 180 Pages
Global
From €4090EUR$4,500USD£3,502GBP
- Report
- March 2025
- 185 Pages
Global
From €4090EUR$4,500USD£3,502GBP
- Report
- March 2025
- 188 Pages
Global
From €4090EUR$4,500USD£3,502GBP
- Report
- January 2025
- 180 Pages
Global
From €4090EUR$4,500USD£3,502GBP
- Report
- November 2024
- 180 Pages
Global
From €4090EUR$4,500USD£3,502GBP

Pneumonia is an infectious disease caused by bacteria, viruses, or fungi that affects the lungs. It is one of the most common infectious diseases and is a leading cause of death worldwide. Infectious disease testing is used to diagnose and monitor the progression of pneumonia. Tests used to diagnose pneumonia include chest X-rays, sputum cultures, and blood tests. Treatment for pneumonia typically involves antibiotics, antivirals, and other medications.
The pneumonia market within the context of infectious disease testing is a rapidly growing market. It is driven by the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis. The market is expected to grow due to the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis.
Some companies in the pneumonia market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more